| Net Loss per Share |
Note 14: Net Loss per Share
Basic loss per share is computed by dividing net loss attributable to vTv Therapeutics Inc. by the weighted-average number of shares of Class A Common Stock outstanding during the period. Diluted loss per share is computed giving effect to all potentially dilutive shares. Diluted loss per share for the years ended December 31, 2017, 2016 and 2015 is the same as basic loss per share as the inclusion of potentially issuable shares would be antidilutive. Loss per share for the year ended December 31, 2015 includes the losses recognized both prior and subsequent to the IPO and Reorganization Transactions.
A reconciliation of the numerator and denominator used in the calculation of basic and diluted net loss per share of Class A Common Stock is as follows (amounts in thousands, except per share amounts):
|
|
Year Ended December 31, |
|
|
|
2017 |
|
|
2016 |
|
|
2015 |
|
|
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
$ |
(54,647 |
) |
|
$ |
(55,353 |
) |
|
$ |
(41,107 |
) |
|
Less: Net loss attributable to noncontrolling interests |
|
(38,503 |
) |
|
|
(39,001 |
) |
|
|
(13,609 |
) |
|
Net loss attributable to vTv Therapeutics Inc., basic and
diluted |
$ |
(16,144 |
) |
|
$ |
(16,352 |
) |
|
$ |
(27,498 |
) |
|
Denominator: |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average vTv Therapeutics Inc. Class A Common
Stock, basic and diluted |
|
9,693,254 |
|
|
|
9,545,527 |
|
|
|
8,276,520 |
|
|
Net loss per share of vTv Therapeutics Inc. Class A
Common Stock, basic and diluted |
$ |
(1.67 |
) |
|
$ |
(1.71 |
) |
|
$ |
(3.32 |
) |
Potentially dilutive securities not included in the calculation of dilutive net loss per share are as follows:
|
|
Year Ended December 31, |
|
|
|
2017 |
|
|
2016 |
|
|
2015 |
|
|
Class B Common Stock (1) |
|
23,119,246 |
|
|
|
23,119,246 |
|
|
|
23,655,814 |
|
|
Common stock options granted under the Plan |
|
1,960,732 |
|
|
|
1,096,101 |
|
|
|
971,934 |
|
|
Restricted stock units |
|
35,000 |
|
|
|
— |
|
|
|
— |
|
|
Common stock options granted under the Letter Agreement |
|
2,283,105 |
|
|
|
— |
|
|
|
— |
|
|
Common stock warrants |
|
388,853 |
|
|
|
152,580 |
|
|
|
— |
|
|
Total |
|
27,786,936 |
|
|
|
24,367,927 |
|
|
|
24,627,748 |
|
|
|
(1) |
Shares of Class B Common Stock do not share in the Company’s earnings and are not participating securities. Accordingly, separate presentation of loss per share of Class B Common Stock under the two-class method has not been provided. Each share of Class B Common Stock (together with a corresponding vTv Unit) is exchangeable for one share of Class A Common Stock. |
|